Back to VANGUARD GROUP INC VANGUARD GROUP INC

IMDXIMDX
6 quarters

Position history for VANGUARD GROUP INCVANGUARD GROUP INC's holdings in ONCOCYTE CORP

VANGUARD GROUP INC holds 526,675 shares of IMDX (ONCOCYTE CORP), worth $4M as of 2025-Q4. The position was increased (+8.2% shares). IMDX represents 0.0% of VANGUARD GROUP INC's portfolio.

Current Value

$4M

Current Shares

526,675

Total Value Change

+$3.3M

Total Shares Change

+281,287

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2025-Q4
Latest
Increased
526,675
+8.2%
$4M0.0%$7.00
29
2025-Q3
Increased
486,738
+0.6%
$1.6M0.0%$3.23
17
2025-Q2
Increased
483,771
+82.2%
$1.5M0.0%$3.20
27
2025-Q1
Increased
265,457
+9.6%
$812,2980.0%$3.21
19
2024-Q4
Decreased
242,206
-1.3%
$576,4500.0%$2.45
0
2024-Q3
First report
245,388
-
$699,3560.0%$2.88
0

Other major holders of IMDX: VANGUARD CAPITAL MANAGEMENT LLC, Alyeska Investment Group, L.P., GEODE CAPITAL MANAGEMENT, LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used